Ken Griffin Cbd Md, Inc. Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.16 - $0.34 $22,516 - $47,846
-140,725 Reduced 87.11%
20,823 $4,000
Q4 2022

Feb 14, 2023
BUY
$0.22 - $15.3 $19,583 - $1.36 Million
89,016 Added 122.73%
161,548 $37,000
Q3 2022

Nov 14, 2022
BUY
$0.0 - $21.78 $0 - $1.28 Million
58,852 Added 430.2%
72,532 $16,000

Others Institutions Holding YCBD

# of Institutions
2
Shares Held
125K
Call Options Held
0
Put Options Held
0
View Full List

About cbdMD, Inc.

YCBD Quotes by TradingView
  • Ticker YCBD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 60,555,600
  • Market Cap $30.9M
  • Description
  • cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, ...
More about YCBD
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email